MMR Vaccine Injection for Advanced Pancreatic Cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether injecting an MMR (measles, mumps, rubella) vaccine directly into a pancreatic tumor can help your immune system fight the cancer. You're eligible if your pancreatic cancer cannot be surgically removed after standard chemotherapy and radiation treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Pancreatic cancer confirmed by biopsy that cannot be removed by surgery, even after chemotherapy and radiation
- Completed standard chemotherapy (like FOLFIRINOX or gemcitabine-based treatment) and radiation therapy 6–12 weeks before starting the study
- Good overall health status (able to carry out daily activities with minimal assistance)
- Blood counts and liver/kidney function within acceptable ranges
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tumor vaccine combined with standard chemotherapy for people with pancreatic cancer that has spread. The vaccine aims to help your immune system fight the cancer, and the chemo helps shrink tumors.
This trial tests a way to give radiation therapy for pancreatic cancer using MRI scans to guide the treatment. It aims to make the radiation more precise and possibly more effective, and you will receive chemotherapy first, followed by radiation.
This trial tests a special, high-dose radiation treatment for pancreatic cancer that has not spread but cannot be removed with surgery. The goal is to shrink the tumor and improve control of the cancer in the abdomen.
This trial tests a new radioactive injection called NRT6008 for people with pancreatic cancer that cannot be surgically removed. It aims to see if the treatment can shrink the tumor and improve survival.
This trial tests a new injectable treatment (NRT6008) given with standard chemotherapy for people whose pancreatic cancer cannot be removed by surgery. The goal is to see if it helps control the tumor better than chemo alone.
This trial tests a precise type of radiation therapy guided by MRI for people with locally advanced pancreatic cancer. It aims to treat the tumor while protecting nearby healthy tissue, potentially improving outcomes after chemotherapy.
Hear when a new Borderline Resectable/Unresectable Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.